Associations between decreased BMP6 expression and tumorigenesis, high malignant potential, and/or poorer survival were reported in patients with breast cancer, gastric cancer, and NSCLC (33–39), whereas opposite associations were reported in prostate cancer (40–42). The gene discussed is BMP6; the disease is breast carcinoma.